UBT251 Injection 2.0 mg and UBT251 Injection Placebo
TUL-UBT251(Ⅱ-1)202404
Phase 2 small_molecule completed
Quick answer
UBT251 Injection 2.0 mg and UBT251 Injection Placebo for Obesity &Amp; Overweight is a Phase 2 program (small_molecule) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).
Program details
- Company
- UNITED THERAPEUTICS Corp
- Indication
- Obesity &Amp; Overweight
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed